Insiders · ALVR

ALVR insider transactions

AlloVir Inc. (ALVR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ALVR

• 438d
  Chief Accounting Officer Hagen Brett R sold $8,135 worth of shares (907 units at $8.97), decreasing direct ownership by 32% to 1,925 units (SEC Form 4)

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 439d
  Amendment: New insider Akkaraju Srinivas claimed ownership of 3,578 shares (SEC Form 3)

  3/A - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 440d
  New insider Samsara Biocapital Gp, Llc claimed ownership of 11,448,081 shares (SEC Form 3)

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  Director Ferrara Napoleone was granted 504,000 shares (SEC Form 4)

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  Director Patel Samir Chandrakant was granted 352,800 shares (SEC Form 4)

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  Chief Medical Officer Feinsod Matthew was granted 4,030 shares (SEC Form 4)

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 4 filed by Officer Oxtoby Andrew

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  Director Akkaraju Srinivas was granted 11,444,503 shares (SEC Form 4)

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 4 filed by Director Adamis Anthony P

  4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 3 filed by new insider Akkaraju Srinivas

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 3 filed by new insider Ferrara Napoleone

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 3 filed by new insider Dybbs Michael

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 3 filed by new insider Patel Samir Chandrakant

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 3 filed by new insider Oxtoby Andrew

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 3 filed by new insider Feinsod Matthew

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 447d
  SEC Form 3 filed by new insider Adamis Anthony P

  3 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
• 469d
  Officer Sinha Vikas sold $3,053 worth of shares (303 units at $10.08), decreasing direct ownership by 0.61% to 49,129 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 469d
  General Counsel Miller Edward sold $1,068 worth of shares (106 units at $10.08), decreasing direct ownership by 2% to 6,517 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 469d
  Chief Accounting Officer Hagen Brett R sold $967 worth of shares (96 units at $10.08), decreasing direct ownership by 3% to 2,832 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 497d
  General Counsel Miller Edward sold $494 worth of shares (52 units at $9.50), decreasing direct ownership by 0.78% to 6,623 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 497d
  Chief Accounting Officer Hagen Brett R sold $342 worth of shares (36 units at $9.51), decreasing direct ownership by 1% to 2,928 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 497d
  Officer Sinha Vikas sold $1,226 worth of shares (129 units at $9.50), decreasing direct ownership by 0.26% to 49,432 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 511d
  General Counsel Miller Edward sold $180 worth of shares (409 units at $0.44), decreasing direct ownership by 0.27% to 153,541 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 511d
  Officer Sinha Vikas sold $431 worth of shares (979 units at $0.44), decreasing direct ownership by 0.09% to 1,139,915 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 511d
  Chief Accounting Officer Hagen Brett R sold $146 worth of shares (332 units at $0.44), decreasing direct ownership by 0.48% to 68,174 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 544d
  General Counsel Miller Edward gifted 57,549 shares and received a gift of 57,549 shares, decreasing direct ownership by 27% to 153,950 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 565d
  Chief Executive Officer Brainard Diana sold $4,775 worth of shares (8,706 units at $0.55), decreasing direct ownership by 1% to 723,363 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 565d
  Chief Accounting Officer Hagen Brett R sold $304 worth of shares (554 units at $0.55), decreasing direct ownership by 0.80% to 68,506 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 565d
  General Counsel Miller Edward sold $237 worth of shares (432 units at $0.55), decreasing direct ownership by 0.20% to 211,499 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 565d
  Officer Sinha Vikas sold $1,748 worth of shares (3,186 units at $0.55), decreasing direct ownership by 0.28% to 1,140,894 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 579d
  General Counsel Miller Edward sold $1,965 worth of shares (2,272 units at $0.86), decreasing direct ownership by 1% to 211,931 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 579d
  Chief Executive Officer Brainard Diana sold $9,176 worth of shares (10,609 units at $0.86), decreasing direct ownership by 1% to 732,069 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 579d
  Chief Accounting Officer Hagen Brett R sold $1,431 worth of shares (1,655 units at $0.86), decreasing direct ownership by 2% to 69,060 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 579d
  Officer Sinha Vikas sold $4,442 worth of shares (5,136 units at $0.86), decreasing direct ownership by 0.45% to 1,144,080 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 593d
  Chief Executive Officer Brainard Diana sold $7,597 worth of shares (9,752 units at $0.78), decreasing direct ownership by 1% to 742,678 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 593d
  Chief Accounting Officer Hagen Brett R sold $746 worth of shares (965 units at $0.77), decreasing direct ownership by 1% to 70,715 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 593d
  General Counsel Miller Edward sold $1,083 worth of shares (1,401 units at $0.77), decreasing direct ownership by 0.65% to 214,203 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 593d
  Officer Sinha Vikas sold $2,649 worth of shares (3,428 units at $0.77), decreasing direct ownership by 0.30% to 1,149,216 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 612d
  Officer Sinha Vikas sold $766 worth of shares (940 units at $0.81), decreasing direct ownership by 0.08% to 1,152,644 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 612d
  Chief Executive Officer Brainard Diana sold $1,216 worth of shares (1,493 units at $0.81), decreasing direct ownership by 0.20% to 752,430 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 612d
  General Counsel Miller Edward sold $307 worth of shares (377 units at $0.81), decreasing direct ownership by 0.17% to 215,604 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 612d
  Chief Accounting Officer Hagen Brett R sold $245 worth of shares (301 units at $0.81), decreasing direct ownership by 0.42% to 71,680 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 655d
  Chief Executive Officer Brainard Diana sold $3,996 worth of shares (5,390 units at $0.74), decreasing direct ownership by 0.71% to 753,923 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 657d
  General Counsel Miller Edward sold $321 worth of shares (422 units at $0.76), decreasing direct ownership by 0.20% to 215,981 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 657d
  Chief Executive Officer Brainard Diana sold $2,348 worth of shares (3,091 units at $0.76), decreasing direct ownership by 0.41% to 759,313 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 657d
  Officer Sinha Vikas sold $2,399 worth of shares (3,159 units at $0.76), decreasing direct ownership by 0.27% to 1,153,584 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 657d
  Chief Accounting Officer Hagen Brett R sold $413 worth of shares (544 units at $0.76), decreasing direct ownership by 0.75% to 71,981 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 670d
  Officer Sinha Vikas sold $3,858 worth of shares (5,251 units at $0.73), decreasing direct ownership by 0.45% to 1,156,743 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 670d
  General Counsel Miller Edward sold $1,707 worth of shares (2,323 units at $0.73), decreasing direct ownership by 1% to 216,403 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 670d
  Chief Executive Officer Brainard Diana sold $7,970 worth of shares (10,847 units at $0.73), decreasing direct ownership by 1% to 762,404 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 670d
  Chief Accounting Officer Hagen Brett R sold $1,243 worth of shares (1,692 units at $0.73), decreasing direct ownership by 2% to 72,525 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 685d
  Chief Accounting Officer Hagen Brett R sold $715 worth of shares (960 units at $0.74), decreasing direct ownership by 1% to 74,217 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 685d
  Chief Executive Officer Brainard Diana sold $7,299 worth of shares (9,731 units at $0.75), decreasing direct ownership by 1% to 773,251 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 685d
  Officer Sinha Vikas sold $2,530 worth of shares (3,400 units at $0.74), decreasing direct ownership by 0.29% to 1,161,994 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 685d
  General Counsel Miller Edward sold $1,035 worth of shares (1,391 units at $0.74), decreasing direct ownership by 0.63% to 218,726 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 705d
  Officer Sinha Vikas sold $676 worth of shares (939 units at $0.72), decreasing direct ownership by 0.08% to 1,165,394 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 705d
  General Counsel Miller Edward sold $273 worth of shares (379 units at $0.72), decreasing direct ownership by 0.17% to 220,117 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 705d
  Chief Accounting Officer Hagen Brett R sold $219 worth of shares (304 units at $0.72), decreasing direct ownership by 0.40% to 75,177 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 705d
  Chief Executive Officer Brainard Diana sold $1,072 worth of shares (1,489 units at $0.72), decreasing direct ownership by 0.19% to 782,982 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)
• 731d
  Adams Derek N. was granted 35,000 shares, increasing direct ownership by 100% to 70,000 units (SEC Form 4)

  4 - Allovir, Inc. (0001754068) (Issuer)